Symtuza Interactions
There are 768 drugs known to interact with Symtuza (cobicistat/darunavir/emtricitabine/tenofovir alafenamide), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 338 are major, 408 are moderate, and 22 are minor.
- View all 768 medications that may interact with Symtuza
- View Symtuza alcohol/food interactions (2)
- View Symtuza disease interactions (11)
Most frequently checked interactions
View interaction reports for Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide) and the medicines listed below.
- alprazolam
- aspirin
- atorvastatin
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- bupropion
- cyclobenzaprine
- Descovy (emtricitabine / tenofovir alafenamide)
- doxycycline
- escitalopram
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- hydroxyzine
- ibuprofen
- lisinopril
- metformin
- montelukast
- multivitamin
- omeprazole
- ondansetron
- prednisone
- quetiapine
- rosuvastatin
- tadalafil
- tamsulosin
- testosterone
- Tivicay (dolutegravir)
- tramadol
- Truvada (emtricitabine / tenofovir disoproxil)
- Vitamin D3 (cholecalciferol)
- vitamin e
Symtuza alcohol/food interactions
There are 2 alcohol/food interactions with Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide).
Symtuza disease interactions
There are 11 disease interactions with Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide) which include:
- hepatotoxicity
- hepatitis B
- hepatotoxicity
- creatinine clearance
- hemodialysis
- renal dysfunction
- hemophilia
- hyperglycemia
- bone toxicity
- liver disease
- renal dysfunction
Report options
More about Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide)
- Symtuza consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (9)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
